SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 29, 2018
Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction
6100 Tower Circle, Suite 1000
|(Address of Principal Executive Offices)||(Zip Code)|
(Registrants Telephone Number, including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|Item 1.01.||Entry into a Material Definitive Agreement.|
On March 29, 2018, Acadia Healthcare Company, Inc., a Delaware corporation (the Company), entered into a Third Refinancing Facilities Amendment (the Amendment) to its Amended and Restated Credit Agreement, dated as of December 31, 2012 (as amended, restated or otherwise modified to date, the Amended and Restated Credit Agreement). As of the execution date thereof, the Amendment replaces the existing Revolving Facility and Tranche A Term Loan with a new Revolving Facility and Tranche A Term Loan, respectively. The Companys line of credit on its Revolving Facility remains at $500.0 million and the Amendment reduces the size of the Tranche A Term Loan from $400.0 million to $380.0 million to reflect the current outstanding principal.
The Amendment reduces the Applicable Rate for the Revolving Facility and the Tranche A Term Loan by amending the definition of Applicable Rate in the Amended and Restated Credit Agreement and replacing the table therein with:
Consolidated Leverage Ratio
|> 3.50:1.0 but < 4.00:1.0||1.75||%||0.75||%||0.25||%|
|> 4.00:1.0 but < 4.50:1.0||2.00||%||1.00||%||0.30||%|
|> 4.50:1.0 but < 5.25:1.0||2.25||%||1.25||%||0.35||%|
The foregoing is only a summary of the material terms of the Amendment and does not purport to be complete, and is qualified in its entirety by reference to the Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10 and incorporated herein by reference.
|Item 2.03.||Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.|
To the extent required, the information set forth in Item 1.01 above is incorporated by reference into this Item 2.03.
|Item 9.01.||Financial Statements and Exhibits.|
|10||Third Refinancing Facilities Amendment, dated March 29, 2018, to the Amended and Restated Credit Agreement, dated December 31, 2012 (as amended, restated or otherwise modified to date), by and among Bank of America, NA (Administrative Agent, Swing Line Lender and L/C Issuer) and the Company, the guarantors listed on the signature pages thereto, and the lenders listed on the signature pages thereto.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|ACADIA HEALTHCARE COMPANY, INC.|
|Date: April 2, 2018||By:|
|Christopher L. Howard|
|Executive Vice President, Secretary and General Counsel|